1-year Study to Assess the Efficacy, Safety and Tolerability of NVA237 in Chronic Obstructive Pulmonary Disease (COPD) - No Study Results Posted

1-year Study to Assess the Efficacy, Safety and Tolerability of NVA237 in Chronic Obstructive Pulmonary Disease (COPD) (GLOW 2)

This study has been completed.

Study NCT00929110 Information provided by Novartis

First Received: June 25, 2009 Last Updated: November 8, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	April 2011 (Final data collection date for primary outcome measure)
Certification - "Seeking New Use":	Submission Date: October 25, 2011